FGFR Inhib Futibatinib 20mg $140

Futibatinib is a targeted therapy. It’s used to treat cholangiocarcinoma, especially when there are FGFR2 fusions. It blocks FGFR signaling, which helps slow down cancer cells’ growth and spread.

The drug is in 4 mg tablet form. Adults usually take 20 mg of it, once a day. Each bottle has 28 tablets.

This is a targeted cancer therapy for specific genetic mutations. You take 20 mg every day. It comes in 4 mg tablets and is sold in bottles of 28 tablets each.